In mice, loss of the phagocytic receptor tyrosine kinases AXL and MerTK not only reduced phagocytosis but also decreased alternative activation of macrophages after ICH, which resulted in delayed hematoma clearance and neurological recovery. This evidence concerns the gene MERTK and hematoma.